Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
09/08/2004 | EP1453949A2 Production of cell suspensions |
09/08/2004 | EP1453909A1 Cereal beta glucan compositions, methods of preparation and uses thereof |
09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
09/08/2004 | EP1453844A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
09/08/2004 | EP1453837A2 Targeted therapeutics and uses thereof |
09/08/2004 | EP1453832A1 Ring fused pyrazole derivatives |
09/08/2004 | EP1453827A1 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
09/08/2004 | EP1453820A1 Substituted 6h-dibenzo c,h]chromenes as estrogenic agents |
09/08/2004 | EP1453811A2 Peroxisome proliferator activated receptor agonists |
09/08/2004 | EP1453810A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
09/08/2004 | EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
09/08/2004 | EP1453795A2 Esters and amides as ppar-alpha agonists |
09/08/2004 | EP1453791A1 Acetyl l-carnitine salt with a dicarboxilic organic acid and process for preparing same |
09/08/2004 | EP1453790A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
09/08/2004 | EP1453788A1 Substituted hydroxyethylamines |
09/08/2004 | EP1453782A2 Substituted phenyl naphthalenes as estrogenic agents |
09/08/2004 | EP1453777A1 Functionalized higher diamondoids |
09/08/2004 | EP1453548A2 Compositions for and methods of treating and preventing sirs/sepsis |
09/08/2004 | EP1453539A2 Immunotherapeutic methods and systems |
09/08/2004 | EP1453532A2 Taojiks as modifiers of the beta-catenin pathway and methods of use |
09/08/2004 | EP1453528A2 Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders |
09/08/2004 | EP1453525A1 Selective targeting of apoptotic cells |
09/08/2004 | EP1453524A2 Breathable gas mixtures to change body temperature |
09/08/2004 | EP1453522A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist |
09/08/2004 | EP1453520A1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
09/08/2004 | EP1453511A1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |
09/08/2004 | EP1453510A2 Neurotransmitter balance chemotherapy |
09/08/2004 | EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
09/08/2004 | EP1453498A1 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production |
09/08/2004 | EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
09/08/2004 | EP1453382A2 Methods and compositions for correction of cardiac conduction disturbances |
09/08/2004 | EP1409510A4 Biological pacemaker |
09/08/2004 | EP1294867B1 Human site-1 protease promoter |
09/08/2004 | EP1289972B1 Serine protease inhibitors |
09/08/2004 | EP1289950B1 Serine protease inhibitors |
09/08/2004 | EP1201664B1 Benzimidazole compounds and drugs containing the same |
09/08/2004 | EP1176971B1 Use of phyllanthus for treating chronic inflammatory and fibrotic processes |
09/08/2004 | EP1150746B1 The use of 4-h-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation |
09/08/2004 | EP1140933B1 Process for preparing n6-substituted deaza-adenosine derivatives |
09/08/2004 | EP1137662B1 Pharmaceutical compositions comprising quinapril magnesium |
09/08/2004 | EP1122243B1 Novel imidazoles with anti-inflammatory activity |
09/08/2004 | EP1094712A4 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
09/08/2004 | EP1089994B1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
09/08/2004 | EP1075474B1 Process for making 1,3-disubstituted-4-oxocyclic ureas |
09/08/2004 | EP1064021B1 Use of cysteinprotease inhibitors for the manufacture of a medicament for prevention and treatment of brain tissue impairment due to hypertensive encephalopathy or encephalothlipsis. |
09/08/2004 | EP0873131B1 Processes for preparation of rg3 and rg5 ginsenosides |
09/08/2004 | EP0739355B1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
09/08/2004 | EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors |
09/08/2004 | CN1527840A Use of CD 25 binding molecules in steroid-resistant patients |
09/08/2004 | CN1527831A Antagonists of MCP-q function and method of use thereof |
09/08/2004 | CN1527828A 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
09/08/2004 | CN1527827A Therapeutic heterocyclic compounds |
09/08/2004 | CN1527824A Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
09/08/2004 | CN1527823A Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
09/08/2004 | CN1527822A Thiazole derivatives for treating PPAR related disorders |
09/08/2004 | CN1527814A Nitric oxide synthase inhibitor phosphate salt |
09/08/2004 | CN1527813A ANtioxidant nitroxides and nitrones as therapeutic agents |
09/08/2004 | CN1527727A Improved chelator conjugates |
09/08/2004 | CN1527719A Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
09/08/2004 | CN1527710A Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
09/08/2004 | CN1527707A The use of substituted azetidinone compounds for the treatment of sitosterolemia |
09/08/2004 | CN1527705A Pharma ceutical formulation containing and LTB4 antagonist |
09/08/2004 | CN1527704A Compositions and method of administering tubulin binding agents for the treatment of ocular diseases |
09/08/2004 | CN1526721A Extraction process of conjugated female hormone |
09/08/2004 | CN1526448A Medicine and method for the treatment of anorectal disorders |
09/08/2004 | CN1526447A Human blood vessel IBP sample growth factor |
09/08/2004 | CN1526433A Compound American ginseng prepn and its prepn process |
09/08/2004 | CN1526432A Medicine for treating piles |
09/08/2004 | CN1526420A Prepn of blood fat reducing granule |
09/08/2004 | CN1526409A Medicated food for preventing and treating several kinds of diseases such as: alcoholism, fatty liver, diabetes and its making process |
09/08/2004 | CN1526402A Use of anthraglucorhein in preparing medicine for treating ischemic cerebral vascular diseases |
09/08/2004 | CN1526401A Medicine composition for treating coronary heart disease and its prepn process, use and guality control method |
09/08/2004 | CN1526398A Compound blood pressure reducing prepn containing angiotonin converzyme inhibitor, calcium ion agonist and Estazolam |
09/08/2004 | CN1526393A Hydralazine hydrochloride guttate pills and the prepn |
09/08/2004 | CN1526380A Metoprolol dripping pills and the prepn process thereof |
09/08/2004 | CN1165550C Synthetic polysaccharides, their method of prodn. and pharmaceutical compositions contg. same |
09/08/2004 | CN1165539C Oxazinocarbazoles for the treatment of CNS diseases |
09/08/2004 | CN1165537C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
09/08/2004 | CN1165536C Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
09/08/2004 | CN1165526C Substituted phenyl cyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
09/08/2004 | CN1165522C Bradykinin receptor antagonists |
09/08/2004 | CN1165518C Biocyclic amino acids compound compound as pharmaceutical agents |
09/08/2004 | CN1165311C Slow-releasing coposition of estrogen medicine and its preparing process |
09/08/2004 | CN1165310C Drug-(combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6- enoic acid and an inhibitor,inducer or substrate of P450 |
09/08/2004 | CN1165309C Stable compositions comprising levosimendan and alginic acid |
09/08/2004 | CN1165305C Lyophilized composition of nimodipine |
09/08/2004 | CN1165304C Nimudipin undertongue spraying agent |
09/08/2004 | CN1165296C Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as coating agent, binding agent and/or film-forming auxiliary agent |
09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
09/07/2004 | US6787566 Breakers of advanced glycation endproducts |
09/07/2004 | US6787561 Benzimidazole compounds |
09/07/2004 | US6787560 Serotonin reuptake inhibitor |
09/07/2004 | US6787558 Neuropeptide y receptor antagonists, for treating arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity |
09/07/2004 | US6787555 Such as 4-(4-fluorophenyl)-5-(2-phenylmethylamino)pyrimidin-4-yl)-1-ethoxymethyl -(1,2,3)triazole for inhibition of release of inflammatory interleukins; for treatment of osteoarthritis, rheumatoid arthritis, and congestive heart failure |
09/07/2004 | US6787554 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives |
09/07/2004 | US6787552 PPAR delta activators |
09/07/2004 | US6787551 Thiazolidinedione derivatives and pharmaceutical composition comprising the same |
09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
09/07/2004 | US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |